Potency Enhancement of the Κ-Opioid Receptor Antagonist Probe ML140 Through Sulfonamide Constraint Utilizing a Tetrahydroisoquinoline Motif

Bioorganic and Medicinal Chemistry - United Kingdom
doi 10.1016/j.bmc.2014.12.033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Role of Κ Opioid Receptor in Brain Ischemia

Critical Care Medicine
Critical CareIntensive Care Medicine
2016English

Studies Toward the Pharmacophore of Salvinorin A, a Potent Κ Opioid Receptor Agonist

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2005English

Catalytic Aerobic Oxidation of Nor-Binaltorphimine (Nor-Bni) Analogs Without 4,5-Epoxy Bridge Affords a More Selective Ligand for Κ Opioid Receptor Than the Representative Κ Antagonist Nor-Bni

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2007English

Regulation of Mouse Κ Opioid Receptor Gene Expression by Retinoids

Journal of Neuroscience
Neuroscience
2001English

Κ-Opioid Receptors Are Implicated in the Increased Potency of Intra-Accumbens Nalmefene in Ethanol-Dependent Rats

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2011English

Κ-Opioid Receptor Is Involved in the Cardioprotection Induced by Exercise Training

PLoS ONE
Multidisciplinary
2017English

Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy Μ Opioid Receptor (MOR) Agonist/Δ Opioid Receptor (DOR) Antagonist Ligands

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

Structure–Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Κ-Opioid Receptor Agonists Modulate Visceral Nociception at a Novel, Peripheral Site of Action

Journal of Neuroscience
Neuroscience
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy